Skip to main content

and
  1. No Access

    Article

    Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes

    To evaluate toxicity and outcomes of moderately hypofractionated helical tomotherapy for the curative treatment of a cohort of patients aged ≥ 75 years with localized prostate cancer (PC).

    F. Cuccia, A. Fiorentino, S. Corrao in Aging Clinical and Experimental Research (2020)